Hypoxia and inflammation

HK Eltzschig, P Carmeliet - New England Journal of Medicine, 2011 - Mass Medical Soc
This review deals with emerging evidence of an association between systemic or local
hypoxia and inflammation in a variety of diseases. The evidence points to new ways of …

Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases

HK Eltzschig, DL Bratton, SP Colgan - Nature Reviews Drug Discovery, 2014 - nature.com
Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes
associated with disorders such as inflammatory bowel disease, pathogen infection and …

Cancer as a metabolic disease

TN Seyfried, LM Shelton - Nutrition & metabolism, 2010 - Springer
Emerging evidence indicates that impaired cellular energy metabolism is the defining
characteristic of nearly all cancers regardless of cellular or tissue origin. In contrast to normal …

Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions

LP Pral, JL Fachi, RO Corrêa, M Colonna… - Trends in …, 2021 - cell.com
Oxygen (O 2) availability is a key factor regulating microbiota composition and the
homeostatic function of cells in the intestinal mucosa of vertebrates. Microbiota-derived …

Hypoxia and tissue destruction in pulmonary TB

M Belton, S Brilha, R Manavaki, F Mauri, K Nijran… - Thorax, 2016 - thorax.bmj.com
Background It is unknown whether lesions in human TB are hypoxic or whether this
influences disease pathology. Human TB is characterised by extensive lung destruction …

HMGB1: the central cytokine for all lymphoid cells

G Li, X Liang, MT Lotze - Frontiers in immunology, 2013 - frontiersin.org
High-mobility group box 1 (HMGB1) is a leaderless cytokine, like the IL-1 and FGF family
members, that has primary roles within the nucleus and the cytosol. Within the nucleus, it …

HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium

T Eckle, K Brodsky, M Bonney, T Packard, J Han… - PLoS …, 2013 - journals.plos.org
Background While acute lung injury (ALI) contributes significantly to critical illness, it
resolves spontaneously in many instances. The majority of patients experiencing ALI require …

Targeting the HIF pathway in inflammation and immunity

CC Scholz, CT Taylor - Current opinion in pharmacology, 2013 - Elsevier
Highlights•Hypoxia is a prominent feature in inflamed tissues.•The HIF pathway is a potential
therapeutic target in inflammation.•Hydroxylase inhibition is anti-inflammatory in models of …

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens

N Werth, C Beerlage, C Rosenberger, AS Yazdi… - PLoS …, 2010 - journals.plos.org
Background Hypoxia inducible factor (HIF)-1 is the key transcriptional factor involved in the
adaptation process of cells and organisms to hypoxia. Recent findings suggest that HIF-1 …

Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury

U Schingnitz, K Hartmann, CF MacManus… - The Journal of …, 2010 - journals.aai.org
Sepsis and septic acute lung injury are among the leading causes for morbidity and mortality
of critical illness. Extracellular adenosine is a signaling molecule implicated in the cellular …